Literature DB >> 2537187

Aldosterone secretion inhibitory factor: a novel neuropeptide in bovine chromaffin cells.

T T Nguyen1, C Lazure, K Babinski, M Chretien, H Ong, A De Lean.   

Abstract

We report the identification and the primary structure of a novel neuroendocrine peptide which inhibits aldosterone secretion. The peptide was isolated from 1.5 x 10(10) cultured bovine chromaffin cells by reversed phase and ion exchange HPLC. It is chromatographically and structurally distinct from atrial natriuretic factor (ANF), which we formely identified in chromaffin tissue. This new Aldosterone Secretion Inhibitory Factor (ASIF) is predominant in cultured chromaffin cells and cross-reacts with ANF receptor sites involved in the inhibition of aldosterone production in zona glomerulosa cells. The sequence of this 35-amino acid peptide includes the shorter fragment isolated from porcine brain confirming its neuropeptide character. ASIF might be involved in concert with ANF in the paracrine regulation of aldosterone secretion and the presence of both peptides in cultured chromaffin cells indicates that this system can be used as a model for studying natriuretic neuropeptide production.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537187     DOI: 10.1210/endo-124-3-1591

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Detection of immunoreactive atrial and brain natriuretic peptides in the equine atrium.

Authors:  H Mifune; R Richter; W G Forssmann
Journal:  Anat Embryol (Berl)       Date:  1995-08

2.  Atrial natriuretic factor mRNA and binding sites in the adrenal gland.

Authors:  D J Nunez; A P Davenport; M J Brown
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

Review 3.  Aldosterone breakthrough from a pharmacological perspective.

Authors:  Masaki Mogi
Journal:  Hypertens Res       Date:  2022-04-14       Impact factor: 5.528

4.  Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system".

Authors:  S Suga; K Nakao; H Itoh; Y Komatsu; Y Ogawa; N Hama; H Imura
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.